Know your journal - International Journal of Molecular and Immuno Oncology (IJOMIO) Ft. Dr. Radhika A. Vaishnav (Executive editor)

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-09-01 06:45 GMT   |   Update On 2023-02-14 11:38 GMT
Advertisement
Molecular oncology is an interdisciplinary medical specialty at the interface of medicinal chemistry and oncology. It basically refers to the investigation of the chemistry of cancer and tumors at the very basic molecular level. IJMIO is a peer-reviewed journal that is published jointly by Molecular Oncology Society and Immuno Oncology Leadership Network and it is published by Scientific Scholar.
So, the International Journal of Molecular and Immuno Oncology (IJMIO) is an open-access peer-reviewed journal which covers this concept. And the journal is committed to publishing high-quality articles in the field of Molecular Biological and Immunological aspects of Oncology.

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News